[{"data":1,"prerenderedAt":133},["ShallowReactive",2],{"drug-sinecatechins":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":21,"regimens":34,"contraindications":56,"warnings":57,"renal":65,"monitoring":66,"interactions":67,"review":68,"examples":71,"atc":72,"iran":74,"usApproval":81,"links":87,"populations":98},"sinecatechins",1,{"fa":7,"en":8},"پماد سینکاتچین (عصاره چای سبز)","Sinecatechins ointment","dermatology",{"fa":11,"en":12},"عصاره چای سبز موضعی (ضد زگیل)","Topical green-tea extract (anti-wart)",[14],{"name":15,"market":16},"Veregen","US",[18,19,20],"veregen","سینکاتچین","پماد چای سبز",[22],{"id":23,"form":24,"route":25,"label":26,"concentration":27,"markets":29,"refs":30},"oint","ointment","topical","Sinecatechins 15% ointment (30 g tube)",{"amount":5,"unit":28,"perUnit":28},"application",[16],[31],{"source":32,"section":33},"fda-veregen","3",[35],{"id":36,"disease":37,"label":38,"population":41,"type":45,"unit":46,"dose":47,"refs":51},"warts","genital-warts",{"fa":39,"en":40},"زگیل خارجی تناسلی و اطراف مقعد (۱۸ سال به بالا) — سه بار در روز تا ۱۶ هفته","External genital and perianal warts (≥18 y) — three times daily up to 16 weeks",{"minAge":42},{"value":43,"unit":44},18,"year","notCalculated","mg",{"reason":48},{"fa":49,"en":50},"حدود ۰٫۵ cm پماد روی هر زگیل با انگشت، لایه نازک؛ سه بار در روز تا پاک شدن کامل، حداکثر ۱۶ هفته. شستن قبل از نوبت بعد لازم نیست. نه برای چشم، دهان، داخل واژن یا داخل مقعد.","About 0.5 cm strand per wart dabbed on with a finger, thin layer; three times daily until complete clearance, max 16 weeks. No need to wash off before the next dose. Not for eye, mouth, intravaginal or intra-anal use.",[52,54],{"source":32,"section":53},"2.1",{"source":32,"section":55},"2.2",[],[58],{"text":59,"refs":62},{"fa":60,"en":61},"برای HPV داخل مجرای ادرار، واژن، دهانه رحم یا مقعد نه؛ روی زخم باز نه؛ ناحیه از نور خورشید و UV دور بماند.","Not for urethral, intravaginal, cervical, rectal or intra-anal HPV disease; avoid open wounds; avoid sun\u002FUV exposure of the treated area.",[63],{"source":32,"section":64},"5",[],[],[],{"status":69,"reviewer":70,"date":70},"unverified",null,[],[73],"D06BB12",{"status":75,"refs":76},"not-found",[77],{"source":78,"section":79,"url":80},"darooyab-generic","search","https:\u002F\u002Fwww.darooyab.ir\u002FSearch?q=Sinecatechins%20ointment",{"kind":82,"refs":83,"id":86},"NDA",[84],{"source":32,"section":85},"SPL approval \u002F marketing category","NDA021902",[88,91,95],{"kind":89,"url":90,"label":86},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=021902",{"kind":92,"url":93,"label":94},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=f0fc1e21-e3cf-4bce-860c-307f670b192e","FDA Veregen",{"kind":96,"url":97,"label":73},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=D06BB12",{"pregnancy":99,"lactation":108,"pediatric":116,"geriatric":125},{"level":100,"text":101,"quote":104,"refs":105},"caution",{"fa":102,"en":103},"برچسب خطر مشخصی برای بارداری ذکر نکرده یا داده کافی ندارد؛ فقط در صورت لزوم و با نظر پزشک.","Label states no clear risk or has limited data; use only if needed, under medical advice.","Risk Summary There are no available data on Veregen use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes.",[106],{"source":32,"section":107},"8.1",{"level":100,"text":109,"quote":112,"refs":113},{"fa":110,"en":111},"برچسب: در شیردهی با احتیاط؛ متن برچسب را ببینید.","Label: use with caution while breastfeeding; see the label text.","Risk Summary There are no data on the presence of sinecatechins in human or animal milk, the effects on the breastfed child, or the effects on milk production.",[114],{"source":32,"section":115},"8.2",{"level":117,"text":118,"quote":121,"refs":122},"not-established",{"fa":119,"en":120},"برچسب: ایمنی و اثربخشی در کودکان ثابت نشده است.","Label: safety and effectiveness in children have not been established.","Safety and effectiveness in pediatric patients have not been established.",[123],{"source":32,"section":124},"8.4",{"level":100,"text":126,"quote":129,"refs":130},{"fa":127,"en":128},"برچسب: در سالمندان با احتیاط و معمولاً از دوز پایین شروع شود.","Label: use with caution in older adults, usually starting at the low end of the dose range.","Seven patients (1.4%), older than 65 years of age were treated with Veregen in clinical studies.",[131],{"source":32,"section":132},"8.5",1792156195384]